You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 269 No. 3, January 20, 1993 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ethical Considerations in Listing Fetuses as Candidates for Neonatal Heart Transplantation

Marian G. Michaels, MD, MPH; Joel Frader, MD; John Armitage, MD

JAMA. 1993;269(3):401-403.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SINCE Dr Christian Barnard performed the first adult heart transplant in 1967, this procedure has evolved into a lifesaving surgery for many people with end-stage cardiac function. The first efforts at neonatal heart transplantation were undertaken in 1967 and 1968.1,2 Both of the infants died within a few hours, temporarily dampening enthusiasm for this procedure in the neonate. In the 1980s, with the advent of improved immunosuppression, solid-organ transplantation became a more feasible treatment for end-stage organ disorders, and interest in neonatal cardiac transplantation was renewed. In the United States, the number of cardiac transplants performed in children less than 1 year of age rose from two in 1984 to 82 in 1990.3 By 1989, surgeons had performed pediatric cardiac transplantation in 61 centers.4 Survival with 4 to 40 months of follow-up ranges between 63% and 84%.5-7 Evaluations to date show normal growth and development of . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Pediatrics (Drs Michaels and Frader), the Center for Medical Ethics (Dr Frader), and the Department of Surgery (Drs Armitage and Michaels), University of Pittsburgh (Pa) School of Medicine, and the Children's Hospital of Pittsburgh.


Footnotes

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.